Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Smooth Muscle Dysfunction Syndrome (SMDS): early-phase trial registry

1 of 1 indexed Smooth Muscle Dysfunction Syndrome (SMDS) trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Smooth Muscle Dysfunction Syndrome (SMDS): 1 US clinical trial tracked, 1 recruiting.

Smooth Muscle Dysfunction Syndrome (SMDS) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is The University of Texas Health Science Center, Houston, running 1 of these trials.

Enrollment posture brief

Registry condition smooth-muscle-dysfunction-syndrome-smds

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Smooth Muscle Dysfunctio (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Smooth Muscle Dysfunction Syndrome (SMDS)

Smooth Muscle Dysfunction Syndrome (SMDS) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Smooth Muscle Dysfunction Syndrome (SMDS) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Smooth Muscle Dysfunction Syndrome (SMDS) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Smooth Muscle Dysfunction Syndrome (SMDS) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Nicotinamide riboside (NR) Drug
1 trials

US sites by state

Facility locations filed on Smooth Muscle Dysfunction Syndrome (SMDS) trials. A trial with sites in several states counts in each.

Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Smooth Muscle Dysfunction Syndrome (SMDS) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Smooth Muscle Dysfunction Syndrome (SMDS) condition card totals 1 registered trials; most-linked intervention Nicotinamide riboside (NR); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.